Internal Medicine, Infectious Disease · Newport News, VA
NPI
1336176403
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
12420 Warwick Blvd Ste 4c
Newport News, VA, 23606
Phone (757) 596-7115
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,159
81 services
Medicare patients, 2024
46
Average age 67
Drug cost, 2024
$2.5M
1,203 prescriptions
Company payments, 2025
$73.5
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrea Gonzalez was code 99233 (hospital e&m - subsequent), 33 times for 17 patients. In total Andrea Gonzalez billed 81 services in 12 codes, and Medicare paid $5,159.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 33 | 17 | $83.79 | $2,765 |
| G2011 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | Office | 18 | 18 | $12.08 | $217 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $122.52 | $1,593 |
By year: 2022 $32K for 498 services; 2023 $23K for 285 services; 2024 $5,159 for 81 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrea Gonzalez prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 231 prescriptions and refills. In total Andrea Gonzalez wrote 1,203 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 231 | 241 | 32 | $920K |
| Tivicay Dolutegravir Sodium | 61 | 77 | Under 11 | $189K |
| Juluca Dolutegravir/Rilpivirine | 56 | 56 | Under 11 | $206K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 53 | 53 | Under 11 | $204K |
| Doxycycline Hyclate Generic | 40 | 50 | 21 | $1,007 |
| Abacavir Abacavir Sulfate | 38 | 60 | Under 11 | $10K |
| Descovy Emtricitabine/Tenofov Alafenam | 38 | 48 | Under 11 | $102K |
| Methenamine Hippurate Generic | 34 | 44 | Under 11 | $1,569 |
| Dovato Dolutegravir Sodium/Lamivudine | 32 | 38 | Under 11 | $119K |
| Gentamicin Sulfate Generic | 31 | 31 | Under 11 | $177 |
| Darunavir Generic | 31 | 31 | Under 11 | $14K |
| Daptomycin Generic | 31 | 31 | Under 11 | $17K |
| Cephalexin Generic | 30 | 44 | 13 | $602 |
| Isentress Raltegravir Potassium | 30 | 30 | Under 11 | $62K |
| Ritonavir Generic | 28 | 36 | Under 11 | $4,498 |
Brand drugs: 660 claims; generic drugs: 543 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrea Gonzalez $73.5 ($73.5 in general payments such as food, travel and fees) from 4 companies. The largest payer was Insmed, Inc. with $26.18.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.